Clinical studies recruiting near Surrey

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Evaluation of the MuSICCA for Measuring Awareness
Phase N/A · The Children's Trust, United Kingdom · NCT04050995 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-11012 Surry, BC Investigational Site · Colorado Prevention Center · NCT06024746 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma R&D · NCT06988605 EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.
Phase N/A · SamanTree Medical SA · NCT07006090 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Phase 1 · Seagen, a wholly owned subsidiary of Pfizer · NCT05208762 The Medacta International SMS Post-Marketing Surveillance Study
Phase N/A · Medacta International SA · NCT02748408 Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Phase 1/Phase 2 · CellCentric Ltd. · NCT04068597 A Platform Trial for Gram Negative Bloodstream Infections
NA · Surrey Memorial Hospital · Sunnybrook Health Sciences Centre · NCT06537609 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Hoffmann-La Roche · NCT07284121 Visugromab in Cachexia International Trial
Phase 2/Phase 3 · CatalYm GmbH · NCT07112196 A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
Phase 2 · Inmagene Site 15 · Inmagene LLC · NCT07037901 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Fraser Health · Boehringer Ingelheim · NCT06531824 Non-invasive Ventilation and Dexmedetomidine in Critically Ill Adults
Phase 3 · Fraser Health Authority · St. Joseph's Healthcare Hamilton · NCT06259565 A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Live
Phase 1 · Bayer · NCT06764316 Insect vs Animal Protein for Building Muscle
NA · University of Surrey · NCT07159919 A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic P
Phase 1 · Genentech, Inc. · NCT05800665 Thromboprophylaxis in Lower Limb Immobilisation
Phase 3 · Queen Mary University of London · NCT06370273 Safety, Performance, and Clinical Benefit of Pacing the Left Bundle Branch Area - Post-Market Clinical Follow-up
Phase N/A · Boston Scientific Corporation · NCT07209852 A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight
Phase 2 · Ocean West Research Clinic (Surrey) · Boehringer Ingelheim · NCT07662122 Chronic Pelvic Pain in Females and Males
Phase N/A · Salem Anaesthesia Pain Clinic · Salem Anaesthesia Pain Clinic · NCT06102733 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-11012 Surrey, BC Investigational Site · Colorado Prevention Center · NCT06033950 A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atop
Phase 3 · Dr. Chih-Ho Hong Medical Inc. · Organon and Co · NCT07265479 The Remote Study: Investigating the Effects or Online Exercise on Quality of Life in Men With Prostate Cancer
NA · University of Surrey · NCT05989854 A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Eli Lilly and Company · NCT07420283 EUthyroid2: the Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europ
NA · EUthyroid · NCT06769009 First-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant
Phase 1 · Bayer · NCT06217822 Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Phase 4 · Novartis Pharmaceuticals · NCT05803941 LND101 for Fecal Microbiota Transplantation in Combination With Immune Checkpoint Blockade in Advanced Melanoma
Phase 2 · BCCA - Surrey · Canadian Cancer Trials Group · NCT06623461 Phase II Randomized Trial of 2 Versus 5 Fraction Prostate Stereotactic Ablative Radiotherapy for Intermediate Risk Prost
Phase 2 · BC Cancer Radiation Oncology · British Columbia Cancer Agency · NCT06835725 Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/Phase 2 · Regeneron Pharmaceuticals · NCT03761108

Look up another city

Look up another condition